Online sales of Opill, the first over-the-counter (OTC) birth control pill authorized in the US, began on Monday, with plans for availability at major retailers like Walgreens and CVS.
Opill, approved by the FDA in July for OTC use, is approximately 93% effective for preventing pregnancy and is safe for individuals as young as 15, without age limitations.
Opill, priced at roughly $20 for one month or $90 for six months, offers a more accessible contraceptive option and does not contain estrogen, making it suitable for individuals who may not tolerate estrogen-containing contraceptives well.
Online sales of the first OTC birth control pill authorized in the US began on Monday. The product is now being rolled out. It will soon be offered at Walgreens and CVS, two of the biggest shops.
Online sales of the first OTC birth control pill authorized in the US began on Monday. The product is now being rolled out. It will soon be offered at Walgreens and CVS, two of the biggest shops. (Photo : by LOU BENOIST/AFP via Getty Images)
The United States authorized the tablet, marketed under the name Opill. FDA for over-the-counter use in July, becoming the first daily birth control to be approved for sale without a prescription in the United States.
According to the FDA, the medication is typically safe and roughly 93% effective for the majority of individuals who may get pregnant, including those as young as 15. The medicine is sold without regard to age limitations at this time.
The pill's online availability is "a major game-changer for women who either aren't near or can't get to a local pharmacy or doctor," as Nancy Chen reported on "CBS Mornings" on Tuesday.
How Much Does Opill Cost?
A supply lasting one month costs roughly $20, while one lasting six months costs $90. Depending on your plan, your insurance may pay for the cost of the medication.
Its producer, Perrigo, also revealed earlier this month that the medication will be available in a three-month supply for a suggested retail price of $49.99.
Opill, a progestin-only pill, must be taken consistently at the same time every day. Unlike combined oral contraceptives, Opill does not contain estrogen, making it a suitable option for individuals who may not tolerate estrogen-containing contraceptives well. Dr. Melissa J. Kottke, an obstetrician-gynecologist based in Atlanta, emphasized the importance of expanding contraceptive access to help individuals achieve their reproductive goals. Dr. Kottke, who served as a paid consultant to Perrigo during the FDA approval process for Opill, highlighted the significance of reducing barriers to obtaining contraception.
Opill is "safe and effective" when used as directed by the FDA. It should not be used with other hormonal birth control methods, such as IUDs (intrauterine devices), or used as a last resort method of contraception.
The FDA states that anyone who currently have or have previously had breast cancer should not take Opill. The FDA sent a news release stating, "Consumers who have any other form of cancer should ask a doctor before using."
